Related scientific articles (all)

Unknown primary tumors: is there a future therapeutic role for immune checkpoint inhibitors?

Authors : Kourie HR, Awada G, Awada A
Year : 2016
Journal : Future Oncol
Volume : 12(4)
Pages : 429-31

Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration.

Authors : Smid M, Rodríguez-González FG, Sieuwerts AM, Salgado R, Prager-Van der Smissen WJ, Vlugt-Daane MV, van Galen A, Nik-Zainal S, Staaf J, Brinkman AB, Van de Vijver MJ, Richardson AL, Fatima A, Berentsen K, Butler A, Martin S, Davies HR, Debets R, Gelder ME, van Deurzen CH, Macgrogan G, Van den Eynden GG, Purdie C, Thompson AM, Caldas C, Span PN, Simpson PT, Lakhani SR, Van Laere S, Desmedt C, Ringnér M, Tommasi S, Eyford J, Broeks A, Vincent-Salomon A, Futreal PA, Knappskog S, King T, Thomas G, Viari A, Langerød A, Børresen-Dale AL, Birney E, Stunnenberg HG, Stratton M, Foekens JA, Martens JW
Year : 2016
Journal : Nat Commun
Volume : 7
Pages : 12910

Loss of ARID1A activates ANXA1, which serves as a predictive biomarker for trastuzumab resistance.

Authors : Berns K, Sonnenblick A, Gennissen A, Brohée S, Hijmans ME, Evers B, Fumagalli D, Desmedt C, Loibl S, Denkert C, Neven P, Guo W, Zhang F, Knijnenburg TA, Bosse T, van der Heijden MS, Hindriksen S, Nijkamp W, Wessels LF, Joensuu H, Mills GB, Beijersbergen RL, Sotiriou C, Bernards R
Year : 2016
Journal : Clin Cancer Res
Volume : 22(21)
Pages : 5238-48

Analyse de : « Tinzaparine ou antivitamines K pour le traitement d’une thromboembolie veineuse dans le contexte d’un cancer ?

Authors : Sculier C
Year : 2016
Journal : Minerva.ebm
Volume : -
Pages : -

Survey on skin-lightening practices and cosmetics in Kigali, Rwanda.

Authors : Kamagaju L, Morandini R, Gahongayire F, Stévigny C, Ghanem G, Pirotte G, Duez P
Year : 2016
Journal : Int J Dermatol
Volume : 55(1)
Pages : 45-51

Increased body mass index as a risk factor in localized prostate cancer treated by radical prostatectomy.

Authors : Goris Gbenou MC, Peltier A, Schulman CC, Velthoven Rv
Year : 2016
Journal : Urol Oncol
Volume : 34(6)
Pages : 254.e1-6

Risk-adapted transplant strategies for high-risk Hodgkin lymphoma: are we there?

Authors : Lewalle P, Wittnebel S
Year : 2016
Journal : Curr Opin Oncol
Volume : 28
Pages : 390-7

EGFR mutation status on brain metastases from non-small cell lung cancer.

Authors : Hsu F, De Caluwe A, Anderson D, Nichol A, Toriumi T, Ho C
Year : 2016
Journal : Lung Cancer
Volume : 96
Pages : 101-7

Progressive multifocal leukoencephalopathy mimicking cerebral metastases in a patient treated for nasopharyngeal carcinoma

Authors : Oualla K, Aoun F, Lemort M, Harrouk A, Latifyan S, Awada A, Georgala A
Year : 2016
Journal : Belgian J Medical Oncology
Volume : 10(7)
Pages : 276-280

Reply to the letter to the editor 'The ESMO Magnitude of Clinical Benefit Scaling Tool: from theory to practice' by Hartmann and the letter 'Comment on ESMO Magnitude of Clinical Benefit Scale' by Muhonen et al.

Authors : Cherny NI, Sullivan R, Dafni U, Kerst JM, Sobrero A, Zielinski C, de Vries EGE, Piccart-Gebhart M
Year : 2016
Journal : Ann Oncol
Volume : 27
Pages : 205-207

Paget bone disease demonstrated on 68Ga-PSMA ligand PET/CT.

Authors : Artigas C, Alexiou J, Garcia C, Wimana Z, Otte FX, Gil T, Van Velthoven R, Flamen P
Year : 2016
Journal : Eur J Nucl Med Mol Imaging
Volume : 43(1)
Pages : 195-6

Oocytes affected by smooth endoplasmic reticulum aggregates: to discard or not to discard?

Authors : Shaw-Jackson C, Thomas AL, Van Beirs N, Ameye L, Colin J, Bertrand E, Becker B, Rozenberg S, Autin C
Year : 2016
Journal : Arch Gynecol Obstet
Volume : 294(1)
Pages : 175-84

Emerging strategies for managing differentiated thyroid cancers refractory to radioiodine.

Authors : Bulotta S, Celano M, Costante G, Russo D
Year : 2016
Journal : Endocrine
Volume : 52(2)
Pages : 214-21

Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers.

Authors : Fumagalli D, Wilson TR, Salgado R, Lu X, Yu J, OBrien C, Walter K, Huw LY, Criscitiello C, Laios I, Jose V, Brown DN, Rothé F, Maetens M, Zardavas D, Savas P, Larsimont D, Piccart-Gebhart M, Michiels S, Lackner MR, Sotiriou C, Loi S
Year : 2016
Journal : Ann Oncol
Volume : 27
Pages : 1860-6

Pharmacodynamics, pharmacokinetics and clinical efficacy of neratinib in HER2-positive breast cancer and breast cancer with HER2 mutations.

Authors : Kourie HR, Chaix M, Gombos A, Aftimos P, Awada A
Year : 2016
Journal : Expert Opin Drug Metab Toxicol
Volume : 12(8)
Pages : 947-57

Langerhans cell number is a strong and independent prognostic factor for head and neck squamous cell carcinomas.

Authors : Kindt N, Descamps G, Seminerio I, Bellier J, Lechien JR, Pottier C, Larsimont D, Journe F, Delvenne P, Saussez S
Year : 2016
Journal : Oral Oncol
Volume : 62
Pages : 1-10

16ème Rencontre Eveline Markiewicz sur les urgences et complications sévères chez le patient cancéreux. Revue Médicale de Bruxelles, 37 (2) :123-125 : 2016.37(2)

Authors : Sculier JP
Year : 2016
Journal : Rev Med Brux
Volume : 37(2
Pages : 123-5

Mesenchymal stromal cells from the foreskin: Tissue isolation, cell characterization and immunobiological properties.

Authors : Najar M, Raicevic G, André T, Fayyad-Kazan H, Pieters K, Bron D, Toungouz M, Lagneaux L
Year : 2016
Journal : Cytotherapy
Volume : 18
Pages : 320-35

Evaluation of the perceptions and cosmetic satisfaction of breast cancer patients undergoing totally implantable vascular access device (TIVAD) placement.

Authors : Liberale G, El Houkayem M, Viste C, Bouazza F, Moreau M, El Nakadi I, Veys I
Year : 2016
Journal : Support Care Cancer
Volume : 24(12)
Pages : 5035-40

Landscape of somatic mutations in 560 breast cancer whole-genome sequences.

Authors : Nik-Zainal S, Davies H, Staaf J, Ramakrishna M, Glodzik D, Zou X, Martincorena I, Alexandrov LB, Martin S, Wedge DC, Van Loo P, Ju YS, Smid M, Brinkman AB, Morganella S, Aure MR, Lingjærde OC, Langerød A, Ringnér M, Ahn SM, Boyault S, Brock JE, Broeks A, Butler A, Desmedt C, Dirix L, Dronov S, Fatima A, Foekens JA, Gerstung M, Hooijer GK, Jang SJ, Jones DR, Kim HY, King TA, Krishnamurthy S, Lee HJ, Lee JY, Li Y, McLaren S, Menzies A, Mustonen V, OMeara S, Pauporté I, Pivot X, Purdie CA, Raine K, Ramakrishnan K, Rodríguez-González FG, Romieu G, Sieuwerts AM, Simpson PT, Shepherd R, Stebbings L, Stefansson OA, Teague J, Tommasi S, Treilleux I, Van den Eynden GG, Vermeulen P, Vincent-Salomon A, Yates L, Caldas C, Veer LV, Tutt A, Knappskog S, Tan BK, Jonkers J, Borg Å, Ueno NT, Sotiriou C, Viari A, Futreal PA, Campbell PJ, Span PN, Van Laere S, Lakhani SR, Eyfjord JE, Thompson AM, Birney E, Stunnenberg HG, Van de Vijver MJ, Martens JW, Børresen-Dale AL, Richardson AL, Kong G, Thomas G, Stratton MR
Year : 2016
Journal : Nature
Volume : 534(7605)
Pages : 47-54